Skip to main content

Qlucore launches AI-based test for bladder cancer

This addition further expands Qlucore's portfolio of advanced testing solutions, which already includes Qlucore Insights Leukemia (AML), Qlucore Insights Lung Cancer and Qlucore Diagnostics Pediatric Leukemia BCP-ALL Test (CE IVDR).

This addition further expands Qlucore's portfolio of advanced testing solutions, which already includes Qlucore Insights Leukaemia (AML), Qlucore Insights Lung Cancer and Qlucore Diagnostics Pediatric Leukaemia BCP-ALL Test (CE IVDR).

Credit: Gorodenkoff/Shutterstock

Qlucore is launching a new Qlucore Insights test (Research Use Only) specifically developed for bladder cancer samples.

Register for FREE to keep reading

Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:

  • Insights into HPC, AI, lab informatics & data
  • Curated content for life sciences, engineering & academia
  • Access to Breakthroughs: real-world computing success
  • Free reports & panels, including the Lab Informatics Guide
  • White Papers & software updates for smarter research

Sign up now

Already a member? Log in here

Your data is protected under our privacy policy.

Scientific Computing World covers

Media Partners